MovDisordV3, PubMed, Curation, bibRecord, 000849

Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant.

Identifieur interne : 000849 ( PubMed/Curation ); précédent : 000848; suivant : 000850

Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant.

Auteurs : Soma Sengupta [États-Unis] ; Daniel Tarsy ; Robin Joyce ; Suriya Jeyapalan

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2013.

RBID : pubmed:23839936

English descriptors

KwdEn :
- Antibodies, Monoclonal, Murine-Derived (therapeutic use), Cerebellum (pathology), Cyclophosphamide (therapeutic use), Female, Humans, Immunologic Factors (therapeutic use), Stiff-Person Syndrome (immunology), Stiff-Person Syndrome (pathology), Stiff-Person Syndrome (therapy), Treatment Outcome.
MESH :
- chemical , therapeutic use : Antibodies, Monoclonal, Murine-Derived, Cyclophosphamide, Immunologic Factors.
- immunology : Stiff-Person Syndrome.
- pathology : Cerebellum, Stiff-Person Syndrome.
- therapy : Stiff-Person Syndrome.
- Female, Humans, Treatment Outcome.

DOI: 10.1002/mds.25574
PubMed: 23839936

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000849

Links to Exploration step

pubmed:23839936

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant.</title>
<author><name sortKey="Sengupta, Soma" sort="Sengupta, Soma" uniqKey="Sengupta S" first="Soma" last="Sengupta">Soma Sengupta</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tarsy, Daniel" sort="Tarsy, Daniel" uniqKey="Tarsy D" first="Daniel" last="Tarsy">Daniel Tarsy</name>
</author>
<author><name sortKey="Joyce, Robin" sort="Joyce, Robin" uniqKey="Joyce R" first="Robin" last="Joyce">Robin Joyce</name>
</author>
<author><name sortKey="Jeyapalan, Suriya" sort="Jeyapalan, Suriya" uniqKey="Jeyapalan S" first="Suriya" last="Jeyapalan">Suriya Jeyapalan</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="doi">10.1002/mds.25574</idno>
<idno type="RBID">pubmed:23839936</idno>
<idno type="pmid">23839936</idno>
<idno type="wicri:Area/PubMed/Corpus">000849</idno>
<idno type="wicri:Area/PubMed/Curation">000849</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant.</title>
<author><name sortKey="Sengupta, Soma" sort="Sengupta, Soma" uniqKey="Sengupta S" first="Soma" last="Sengupta">Soma Sengupta</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tarsy, Daniel" sort="Tarsy, Daniel" uniqKey="Tarsy D" first="Daniel" last="Tarsy">Daniel Tarsy</name>
</author>
<author><name sortKey="Joyce, Robin" sort="Joyce, Robin" uniqKey="Joyce R" first="Robin" last="Joyce">Robin Joyce</name>
</author>
<author><name sortKey="Jeyapalan, Suriya" sort="Jeyapalan, Suriya" uniqKey="Jeyapalan S" first="Suriya" last="Jeyapalan">Suriya Jeyapalan</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Monoclonal, Murine-Derived (therapeutic use)</term>
<term>Cerebellum (pathology)</term>
<term>Cyclophosphamide (therapeutic use)</term>
<term>Female</term>
<term>Humans</term>
<term>Immunologic Factors (therapeutic use)</term>
<term>Stiff-Person Syndrome (immunology)</term>
<term>Stiff-Person Syndrome (pathology)</term>
<term>Stiff-Person Syndrome (therapy)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antibodies, Monoclonal, Murine-Derived</term>
<term>Cyclophosphamide</term>
<term>Immunologic Factors</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Stiff-Person Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Cerebellum</term>
<term>Stiff-Person Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Stiff-Person Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">23839936</PMID>
<DateCreated><Year>2013</Year>
<Month>11</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>06</Month>
<Day>27</Day>
</DateCompleted>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>28</Volume>
<Issue>13</Issue>
<PubDate><Year>2013</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant.</ArticleTitle>
<Pagination><MedlinePgn>1905-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.25574</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sengupta</LastName>
<ForeName>Soma</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tarsy</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Joyce</LastName>
<ForeName>Robin</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jeyapalan</LastName>
<ForeName>Suriya</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>07</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D058846">Antibodies, Monoclonal, Murine-Derived</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C092560">rituximab</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>8N3DW7272P</RegistryNumber>
<NameOfSubstance UI="D003520">Cyclophosphamide</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D058846">Antibodies, Monoclonal, Murine-Derived</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002531">Cerebellum</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003520">Cyclophosphamide</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007155">Immunologic Factors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016750">Stiff-Person Syndrome</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year>
<Month>2</Month>
<Day>8</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2013</Year>
<Month>3</Month>
<Day>8</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2013</Year>
<Month>5</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2013</Year>
<Month>7</Month>
<Day>9</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>7</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>7</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>6</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.25574</ArticleId>
<ArticleId IdType="pubmed">23839936</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000849 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000849 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:23839936
   |texte=   Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:23839936" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant.

Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant.

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki